Compare McKesson Corporation (MCK) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Prudential Financial Inc — how do they compare? McKesson Corporation trades at $882.01 (market cap $105.14B), while Prudential Financial Inc trades at $122.66 (market cap $42.20B). The key difference: McKesson Corporation is far larger — about 2.5× Prudential Financial Inc's market cap, and Prudential Financial Inc pays the higher dividend (4.58%). Which is the better fit depends on your goals.
| MCK | PRU | |
|---|---|---|
Market Cap | $105.14B | $42.20B |
Sector | Health | Financials |
52-Week High | $995.69 | $123.93 |
52-Week Low | $659.01 | $92.00 |
Enterprise Value | $111.67B | $70.98B |
Dividend Yield | 0.42% | 4.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $889.01, up 1.04% today, with a bullish technical outlook and strong institutional support. Recent Q1 2027 earnings beat expectations, with EPS of $9.93 versus $9.56, driven by specialty drug growth and oncology performance. Revenue reached $359.05B in 2025, with net income of $3.30B, though margins remain thin. The company raised full-year guidance, reflecting operational momentum.
The stock offers upside to the consensus price target of $990.67, supported by 80% analyst buy ratings. Key risks include reliance on pharmaceutical distribution margins, regulatory pressures, and competitive threats. Earnings consistency and cost discipline are critical for sustaining valuation multiples amid healthcare sector volatility.
PRU trades at $122.34, up 0.19% today, with a bullish technical signal from moving averages and support near $122. Recent Q2 2026 earnings beat estimates at $4.08 EPS, driven by strong PGIM and international performance. The company maintains a solid net income margin of 6.04% and ROE of 12.46%, with a dividend of $1.40 declared for September 2026. Revenue trends show growth from 2022 lows, reaching $61.0B in 2025.
Outlook is cautiously optimistic with earnings momentum and strategic focus on capital-light operations, but risks include sensitivity to interest rates and China regulatory news. Analysts are mixed with a $113.11 consensus target below current price, suggesting limited upside. Institutional holdings grew, as seen with Assenagon's 379.8% stake increase in Q2 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
